The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
Asthma: Drug combo leaves many with uncontrolled disease Many people who take inhaled steroids combined with long-acting β2-agonist drugs still have poorly controlled asthma. A team led by Ian Pavord from the University of Oxford, UK, identified 701 people from the 2010–2011 UK National Health and W...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0d36bb18ba614775b04b5f1fea03b7ec |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0d36bb18ba614775b04b5f1fea03b7ec |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0d36bb18ba614775b04b5f1fea03b7ec2021-12-02T15:18:51ZThe impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis10.1038/s41533-017-0014-12055-1010https://doaj.org/article/0d36bb18ba614775b04b5f1fea03b7ec2017-03-01T00:00:00Zhttps://doi.org/10.1038/s41533-017-0014-1https://doaj.org/toc/2055-1010Asthma: Drug combo leaves many with uncontrolled disease Many people who take inhaled steroids combined with long-acting β2-agonist drugs still have poorly controlled asthma. A team led by Ian Pavord from the University of Oxford, UK, identified 701 people from the 2010–2011 UK National Health and Wellness Surveys who were taking this drug combination for their asthma. The researchers found that nearly two-thirds of these individuals had poorly controlled asthma associated with more visits to the emergency room, worse quality of life (both mentally and physically), impaired productivity and other health problems. The calculated direct and indirect costs per person with poorly controlled asthma were about double that for someone whose asthma was under control. The authors conclude that better treatment and management is needed to reduce costs and address the unmet medical need for people with persistent uncontrolled asthma.Ian D. PavordNicola MathiesonAnna ScowcroftRiccardo PedersiniGina IsherwoodDavid PriceNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 27, Iss 1, Pp 1-8 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Diseases of the respiratory system RC705-779 |
| spellingShingle |
Diseases of the respiratory system RC705-779 Ian D. Pavord Nicola Mathieson Anna Scowcroft Riccardo Pedersini Gina Isherwood David Price The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis |
| description |
Asthma: Drug combo leaves many with uncontrolled disease Many people who take inhaled steroids combined with long-acting β2-agonist drugs still have poorly controlled asthma. A team led by Ian Pavord from the University of Oxford, UK, identified 701 people from the 2010–2011 UK National Health and Wellness Surveys who were taking this drug combination for their asthma. The researchers found that nearly two-thirds of these individuals had poorly controlled asthma associated with more visits to the emergency room, worse quality of life (both mentally and physically), impaired productivity and other health problems. The calculated direct and indirect costs per person with poorly controlled asthma were about double that for someone whose asthma was under control. The authors conclude that better treatment and management is needed to reduce costs and address the unmet medical need for people with persistent uncontrolled asthma. |
| format |
article |
| author |
Ian D. Pavord Nicola Mathieson Anna Scowcroft Riccardo Pedersini Gina Isherwood David Price |
| author_facet |
Ian D. Pavord Nicola Mathieson Anna Scowcroft Riccardo Pedersini Gina Isherwood David Price |
| author_sort |
Ian D. Pavord |
| title |
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis |
| title_short |
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis |
| title_full |
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis |
| title_fullStr |
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis |
| title_full_unstemmed |
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis |
| title_sort |
impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the united kingdom: a cross-sectional analysis |
| publisher |
Nature Portfolio |
| publishDate |
2017 |
| url |
https://doaj.org/article/0d36bb18ba614775b04b5f1fea03b7ec |
| work_keys_str_mv |
AT iandpavord theimpactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT nicolamathieson theimpactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT annascowcroft theimpactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT riccardopedersini theimpactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT ginaisherwood theimpactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT davidprice theimpactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT iandpavord impactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT nicolamathieson impactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT annascowcroft impactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT riccardopedersini impactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT ginaisherwood impactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis AT davidprice impactofpoorasthmacontrolamongasthmapatientstreatedwithinhaledcorticosteroidspluslongactingb2agonistsintheunitedkingdomacrosssectionalanalysis |
| _version_ |
1718387431005224960 |